This article is making the rounds and getting some attention. The post below addresses the issues raised. (originally posted on 10/31/2014) ==================================== This article has been forwarded to me by several people. Its author has been writing a series of articles that seek to redefine addiction and recovery. As Eve Tushnet recently observed, "There’s another narrative, … Continue reading Who’s “we”?
This article has been forwarded to me by several people. Its author has been writing a series of articles that seek to redefine addiction and recovery. As Eve Tushnet recently observed, "There’s another narrative, though, which is emerging at sites like The Fix and Substance.com." This sentence is representative of this alternative narative: "The addiction field has struggled … Continue reading Who’s “we”?
I missed this a while back. Turns out that ASAM's president works for a buprenorphine manufacturer. Stuart Gitlow, M.D., is the president of the American Society of Addiction Medicine (ASAM) and also medical director — as a consultant — for Orexo, which makes Zubsolv, a newly approved buprenorphine-naloxone medication (see ADAW, July 15). The first public … Continue reading ASAM president also medical director for drug company
From the NY Times: Addiction experts protested loudly when the Food and Drug Administration approved a powerful new opioid painkiller last month, saying that it would set off a wave of abuse much as OxyContin did when it first appeared. An F.D.A. panel had earlier voted, 11 to 2, against approval of the drug, Zohydro, … Continue reading Who’s guarding the hen house?
Terry Gorski has a nice summary of substance use disorders in the DSM-5. Here's his analysis at the end of the post: The DSM 5 is criticized for combining the the DSM IV categories of substance dependence (addiction marked by a pattern of compulsive use or loss of control) and substance abuse disorders (using in … Continue reading DSM 5 Substance Use Disorders: A Concise Summary
This is very welcome news: Frustrated that medication-assisted treatment is coming across as the addiction field’s standard of care simply because drug company studies are dominating the research landscape, a group of some of the most prominent leaders in treatment administration is vowing to fight back. These leaders have enlisted the help of another heavy … Continue reading NAATP launches counteroffensive to medication push